<p>根据 Benzinga 的报道，银行美林的股票研究人员在周一发布的报告中将 <strong>直觉外科</strong>（NASDAQ:ISRG - 获取免费报告）的目标价格从 650.00 美元下调至 520.00 美元。该券商目前对这家医疗设备提供商的股票给予 “买入” 评级。美林的目标价格表明，相较于公司之前的收盘价，存在 18.97% 的潜在上涨空间。</p>
<p>获取 <strong>直觉外科</strong> 的提醒：</p>
<ul>
<li>直觉外科的抛售为 30% 的反弹机会铺平道路</li>
</ul>
<p>其他一些研究分析师最近也对 ISRG 发表了评论。Leerink Partners 将直觉外科的股票目标价从 622.00 美元下调至 573.00 美元，并在 4 月 22 日的研究报告中给予该公司 “跑赢大盘” 的评级。Piper Sandler 将直觉外科的股票目标价从 620.00 美元下调至 580.00 美元，并在 4 月 22 日的研究报告中给予该公司 “增持” 的评级。摩根大通将直觉外科的目标价从 625.00 美元下调至 550.00 美元，并在 4 月 22 日的报告中给予该公司 “增持” 的评级。TD Cowen 将直觉外科的目标价从 660.00 美元下调至 585.00 美元，并在 4 月 22 日的报告中给予该公司 “买入” 的评级。最后，汇丰将直觉外科的目标价从 653.00 美元下调至 604.00 美元，并在 4 月 22 日的报告中给予该公司 “买入” 的评级。十九位研究分析师对该股票给予了买入评级，七位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，直觉外科目前的共识评级为 “适度买入”，平均目标价为 579.33 美元。</p>
<p><strong>阅读我们关于直觉外科的最新报告</strong></p>
<h2>直觉外科的价格表现</h2>
<ul>
<li>5 只股票在 AI 推动下快速上涨</li>
</ul>
<p>在周一的交易中，ISRG 上涨了 15.95 美元，达到了 437.07 美元。该公司的股票交易量为 994,654 股，而其平均交易量为 2,028,287 股。该公司的 50 日移动平均价格为 463.63 美元，200 日移动平均价格为 513.77 美元。该股票的市值为 1547.9 亿美元，市盈率为 53.00，市盈增长比率为 3.36，贝塔值为 1.51。直觉外科的 12 个月低点为 417.74 美元，12 个月高点为 603.88 美元。</p>
<p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近在 4 月 21 日发布了季度财报。该医疗设备提供商报告每股收益为 2.50 美元，超出市场共识预期的 2.08 美元，超出幅度为 0.42 美元。该公司在本季度的收入为 27.7 亿美元，而市场共识预期为 26.2 亿美元。直觉外科的股本回报率为 15.98%，净利润率为 28.15%。直觉外科的收入同比增长 23.0%。在去年同期，该公司每股收益为 1.81 美元。股票分析师预计，直觉外科在当前年度将发布每股收益 8.57 美元。</p>
<h2>直觉外科的内部交易</h2>
<ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股票</li>
</ul>
<p>在相关消息中，董事 Amy L. Ladd 在 4 月 29 日的交易中出售了 119 股该股票。该股票以平均价格 463.50 美元出售，总价值为 55,156.50 美元。出售完成后，该董事直接持有 120 股公司股票，价值约为 55,620 美元。这代表其持股比例减少了 49.79%。该交易在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，执行副总裁 Gary Loeb 在 5 月 11 日的交易中出售了 400 股该股票。该股票以平均价格 446.95 美元出售，总交易额为 178,780.00 美元。出售完成后，该执行副总裁直接持有 6,120 股公司股票，价值为 2,735,334 美元。这笔交易代表其持股比例减少了 6.13%。有关此交易的更多细节可在官方 SEC 披露中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。内部人士在上个季度出售了价值 2,760,359 美元的 5,647 股公司股票。公司内部人士持有 0.60% 的股票。</p>
<h2>直觉外科的机构交易</h2>
<p>几家大型投资者最近买入和卖出了该公司的股票。挪威银行在第四季度购买了直觉外科的新股份，价值 2,856,987,000 美元。J. Stern &amp; Co. LLP 在第四季度将其在直觉外科的股份增加了 18,504.6%。J. Stern &amp; Co. LLP 现在拥有 2,127,248 股该医疗设备提供商的股票，价值 1,204,788,000 美元，此前在上个季度又购买了 2,115,814 股。西北互助财富管理公司在第四季度将其在直觉外科的股份增加了 1,043.3%。西北互助财富管理公司现在拥有 1,342,121 股该医疗设备提供商的股票，价值 760,124,000 美元，此前在上个季度又购买了 1,224,734 股。Arrowstreet Capital Limited Partnership 在第一季度将其在直觉外科的股份增加了 95.3%。Arrowstreet Capital Limited Partnership 现在拥有 2,105,544 股该医疗设备提供商的股票，价值 970,635,000 美元，此前在上个季度又购买了 1,027,475 股。最后，乐天投资管理公司在第三季度购买了直觉外科的新股份，价值 388,436,000 美元。机构投资者和对冲基金持有该公司 83.64% 的股票。</p>
<h2>关于直觉外科</h2>
<p>（获取免费报告）</p>
<p>直觉外科成立于 1995 年，总部位于加利福尼亚州的阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗科技公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉外科的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室内的精确度、可视化和控制能力。</p>
<p>除了核心手术平台外，直觉外科还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比直觉外科更好的股票</li>
<li>为什么应用光电子股票可能接近转折点</li>
<li>从高收益到高增长：三只提升股息的股票</li>
<li>Everspin Technologies 会是下一个 AI 边缘突破吗？</li>
<li>5 只机器人股票值得关注，因为物理 AI 正在蓬勃发展</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
<p>在考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

直觉外科

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

ISUL

<p>美国银行已将直觉外科（NASDAQ:ISRG）的目标价格从 650.00 美元下调至 520.00 美元，同时维持 “买入” 评级。其他分析师也降低了他们的目标价格，普遍评级为 “适度买入”，平均目标价格为 579.33 美元。直觉外科的股票目前交易价格为 437.07 美元，市值为 1547.9 亿美元，市盈率为 53.00</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price target reduced by equities researchers at Bank of America from $650.00 to $520.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a &#34;buy&#34; rating on the medical equipment provider's stock. Bank of America's target price indicates a potential upside of 18.97% from the company's previous close.</p>
<div class="lb-trans"><p>根据 Benzinga 的报道，银行美林的股票研究人员在周一发布的报告中将 <strong>直觉外科</strong>（NASDAQ:ISRG - 获取免费报告）的目标价格从 650.00 美元下调至 520.00 美元。该券商目前对这家医疗设备提供商的股票给予 “买入” 评级。美林的目标价格表明，相较于公司之前的收盘价，存在 18.97% 的潜在上涨空间。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>直觉外科</strong> 的提醒：</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>直觉外科的抛售为 30% 的反弹机会铺平道路</li>
</ul>
</div><p>A number of other research analysts also recently commented on ISRG. Leerink Partners dropped their price objective on shares of Intuitive Surgical from $622.00 to $573.00 and set an &#34;outperform&#34; rating for the company in a research note on Wednesday, April 22nd. Piper Sandler dropped their price objective on shares of Intuitive Surgical from $620.00 to $580.00 and set an &#34;overweight&#34; rating for the company in a research note on Wednesday, April 22nd. JPMorgan Chase &amp; Co. dropped their price objective on Intuitive Surgical from $625.00 to $550.00 and set an &#34;overweight&#34; rating for the company in a report on Wednesday, April 22nd. TD Cowen dropped their price objective on Intuitive Surgical from $660.00 to $585.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, April 22nd. Finally, HSBC dropped their price objective on Intuitive Surgical from $653.00 to $604.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $579.33.</p>
<div class="lb-trans"><p>其他一些研究分析师最近也对 ISRG 发表了评论。Leerink Partners 将直觉外科的股票目标价从 622.00 美元下调至 573.00 美元，并在 4 月 22 日的研究报告中给予该公司 “跑赢大盘” 的评级。Piper Sandler 将直觉外科的股票目标价从 620.00 美元下调至 580.00 美元，并在 4 月 22 日的研究报告中给予该公司 “增持” 的评级。摩根大通将直觉外科的目标价从 625.00 美元下调至 550.00 美元，并在 4 月 22 日的报告中给予该公司 “增持” 的评级。TD Cowen 将直觉外科的目标价从 660.00 美元下调至 585.00 美元，并在 4 月 22 日的报告中给予该公司 “买入” 的评级。最后，汇丰将直觉外科的目标价从 653.00 美元下调至 604.00 美元，并在 4 月 22 日的报告中给予该公司 “买入” 的评级。十九位研究分析师对该股票给予了买入评级，七位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，直觉外科目前的共识评级为 “适度买入”，平均目标价为 579.33 美元。</p>
</div><p><strong>Read Our Latest Report on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于直觉外科的最新报告</strong></p>
</div><h2>Intuitive Surgical Price Performance</h2>
<div class="lb-trans"><h2>直觉外科的价格表现</h2>
</div><ul>
<li>5 Stocks Racing Ahead as AI Supercharges Robotics</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只股票在 AI 推动下快速上涨</li>
</ul>
</div><p>ISRG traded up $15.95 during trading on Monday, hitting $437.07. The company's stock had a trading volume of 994,654 shares, compared to its average volume of 2,028,287. The firm's 50 day moving average price is $463.63 and its 200-day moving average price is $513.77. The stock has a market cap of $154.79 billion, a PE ratio of 53.00, a PEG ratio of 3.36 and a beta of 1.51. Intuitive Surgical has a twelve month low of $417.74 and a twelve month high of $603.88.</p>
<div class="lb-trans"><p>在周一的交易中，ISRG 上涨了 15.95 美元，达到了 437.07 美元。该公司的股票交易量为 994,654 股，而其平均交易量为 2,028,287 股。该公司的 50 日移动平均价格为 463.63 美元，200 日移动平均价格为 513.77 美元。该股票的市值为 1547.9 亿美元，市盈率为 53.00，市盈增长比率为 3.36，贝塔值为 1.51。直觉外科的 12 个月低点为 417.74 美元，12 个月高点为 603.88 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical's revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.81 EPS. Equities analysts anticipate that Intuitive Surgical will post 8.57 earnings per share for the current year.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近在 4 月 21 日发布了季度财报。该医疗设备提供商报告每股收益为 2.50 美元，超出市场共识预期的 2.08 美元，超出幅度为 0.42 美元。该公司在本季度的收入为 27.7 亿美元，而市场共识预期为 26.2 亿美元。直觉外科的股本回报率为 15.98%，净利润率为 28.15%。直觉外科的收入同比增长 23.0%。在去年同期，该公司每股收益为 1.81 美元。股票分析师预计，直觉外科在当前年度将发布每股收益 8.57 美元。</p>
</div><h2>Insider Transactions at Intuitive Surgical</h2>
<div class="lb-trans"><h2>直觉外科的内部交易</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股票</li>
</ul>
</div><p>In related news, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the sale, the director directly owned 120 shares in the company, valued at approximately $55,620. This represents a 49.79% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $446.95, for a total transaction of $178,780.00. Following the completion of the sale, the executive vice president directly owned 6,120 shares of the company's stock, valued at $2,735,334. This trade represents a 6.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 5,647 shares of company stock worth $2,760,359 in the last quarter. 0.60% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Amy L. Ladd 在 4 月 29 日的交易中出售了 119 股该股票。该股票以平均价格 463.50 美元出售，总价值为 55,156.50 美元。出售完成后，该董事直接持有 120 股公司股票，价值约为 55,620 美元。这代表其持股比例减少了 49.79%。该交易在向证券交易委员会提交的文件中披露，文件可通过 SEC 网站访问。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，执行副总裁 Gary Loeb 在 5 月 11 日的交易中出售了 400 股该股票。该股票以平均价格 446.95 美元出售，总交易额为 178,780.00 美元。出售完成后，该执行副总裁直接持有 6,120 股公司股票，价值为 2,735,334 美元。这笔交易代表其持股比例减少了 6.13%。有关此交易的更多细节可在官方 SEC 披露中找到。该交易是在预先安排的 10b5-1 交易计划下执行的。内部人士在上个季度出售了价值 2,760,359 美元的 5,647 股公司股票。公司内部人士持有 0.60% 的股票。</p>
</div><h2>Institutional Trading of Intuitive Surgical</h2>
<div class="lb-trans"><h2>直觉外科的机构交易</h2>
</div><p>Several large investors have recently bought and sold shares of the company. Norges Bank bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $2,856,987,000. J. Stern &amp; Co. LLP increased its stake in shares of Intuitive Surgical by 18,504.6% in the fourth quarter. J. Stern &amp; Co. LLP now owns 2,127,248 shares of the medical equipment provider's stock worth $1,204,788,000 after buying an additional 2,115,814 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Intuitive Surgical by 1,043.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider's stock worth $760,124,000 after buying an additional 1,224,734 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after buying an additional 1,027,475 shares during the last quarter. Finally, Rakuten Investment Management Inc. bought a new stake in shares of Intuitive Surgical in the third quarter worth $388,436,000. Institutional investors and hedge funds own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>几家大型投资者最近买入和卖出了该公司的股票。挪威银行在第四季度购买了直觉外科的新股份，价值 2,856,987,000 美元。J. Stern &amp; Co. LLP 在第四季度将其在直觉外科的股份增加了 18,504.6%。J. Stern &amp; Co. LLP 现在拥有 2,127,248 股该医疗设备提供商的股票，价值 1,204,788,000 美元，此前在上个季度又购买了 2,115,814 股。西北互助财富管理公司在第四季度将其在直觉外科的股份增加了 1,043.3%。西北互助财富管理公司现在拥有 1,342,121 股该医疗设备提供商的股票，价值 760,124,000 美元，此前在上个季度又购买了 1,224,734 股。Arrowstreet Capital Limited Partnership 在第一季度将其在直觉外科的股份增加了 95.3%。Arrowstreet Capital Limited Partnership 现在拥有 2,105,544 股该医疗设备提供商的股票，价值 970,635,000 美元，此前在上个季度又购买了 1,027,475 股。最后，乐天投资管理公司在第三季度购买了直觉外科的新股份，价值 388,436,000 美元。机构投资者和对冲基金持有该公司 83.64% 的股票。</p>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>关于直觉外科</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直觉外科成立于 1995 年，总部位于加利福尼亚州的阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗科技公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉外科的业务主要集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室内的精确度、可视化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手术平台外，直觉外科还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Why Applied Optoelectronics Stock May Be Near a Turning Point</li>
<li>From High-Yield to High-Growth: 3 Stocks Boosting Dividends</li>
<li>Is Everspin Technologies the Next AI Edge Breakout?</li>
<li>5 Robotics Stocks to Watch as Physical AI Builds Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比直觉外科更好的股票</li>
<li>为什么应用光电子股票可能接近转折点</li>
<li>从高收益到高增长：三只提升股息的股票</li>
<li>Everspin Technologies 会是下一个 AI 边缘突破吗？</li>
<li>5 只机器人股票值得关注，因为物理 AI 正在蓬勃发展</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

美国银行下调了 Intuitive Surgical（NASDAQ:ISRG）股票价格的预期